Search Within

Violante Currie

Formats
  1. Journal Article (32)
  2. Meeting Abstract (14)
  3. Conference Paper (4)
  4. Book Section (1)
Groups
  1. Breast Medicine Service (35)
  2. Department of Medicine (35)
  3. Solid Tumor Oncology Division (35)
  4. Survivorship Research (35)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (34)
  6. Behavioral Sciences Service (25)

More Groups

People
  1. Clifford Hudis (35)
  2. Larry Norton (34)
  3. Andrew Seidman (32)
  4. Teresa Gilewski (25)
  5. Mary Ellen Moynahan (17)
  6. Maria Theodoulou-Haber (16)

More People

Years
  1. 2009 (1)
  2. 2008 (1)
  3. 2006 (4)
  4. 2005 (2)
  5. 2004 (1)
  6. 2001 (3)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Breast Cancer Research and Treatment (9)
  3. Cancer (4)
  4. Seminars in Oncology (4)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  6. Cancer Investigation (2)

More Publications

Publishers
  1. Springer (12)
  2. American Society of Clinical Oncology (10)
  3. American Association for Cancer Research (6)
  4. Elsevier Inc. (6)
  5. Wiley Blackwell (6)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
    Meeting Abstract

    Hurria, A.; Goldfarb, S.; Rosen, C.; Holland, J.; Zuckerman, E.; Lachs, M.; Witmer, M.; van Gorp, W.; Fornier, M.; D'Andrea, G.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Zuckerman, E.; Panageas, K. S.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
    Journal Article

    Hurria, A.; Goldfarb, S.; Rosen, C.; Holland, J.; Zuckerman, E.; Lachs, M. S.; Witmer, M.; Van Gorp, W. G.; Fornier, M.; D'Andrea, G.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life
    Meeting Abstract

    Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save